Entity Common Stock, Shares Outstanding of Pharma-Bio Serv, Inc. from 09 Sep 2011 to 23 Feb 2026

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Pharma-Bio Serv, Inc. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 09 Sep 2011 to 23 Feb 2026.
  • Pharma-Bio Serv, Inc. Entity Common Stock, Shares Outstanding for the quarter ending 23 Feb 2026 was 22,904,492, a 0.12% decline year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Pharma-Bio Serv, Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2026 22,904,492 -26,350 -0.12% 23 Feb 2026 10-K/A 27 Feb 2026 2025 FY
Q4 2025 22,904,492 -53,651 -0.23% 23 Jan 2026 10-K 29 Jan 2026 2025 FY
Q3 2025 22,918,092 -40,051 -0.17% 10 Sep 2025 10-Q 15 Sep 2025 2025 Q3
Q2 2025 22,927,942 -30,201 -0.13% 10 Jun 2025 10-Q 16 Jun 2025 2025 Q2
Q1 2025 22,930,842 -30,301 -0.13% 12 Mar 2025 10-Q 17 Mar 2025 2025 Q1
Q4 2024 22,958,143 -5,000 -0.02% 24 Jan 2025 10-K/A 28 Feb 2025 2024 FY
Q3 2024 22,958,143 -5,308 -0.02% 10 Sep 2024 10-Q 16 Sep 2024 2024 Q3
Q2 2024 22,958,143 -7,408 -0.03% 10 Jun 2024 10-Q 14 Jun 2024 2024 Q2
Q1 2024 22,961,143 -5,472 -0.02% 11 Mar 2024 10-Q 18 Mar 2024 2024 Q1
Q4 2023 22,963,143 +12,822 +0.06% 19 Jan 2024 10-K 29 Jan 2024 2023 FY
Q3 2023 22,963,451 +19,165 +0.08% 08 Sep 2023 10-Q 14 Sep 2023 2023 Q3
Q2 2023 22,965,551 +11,465 +0.05% 09 Jun 2023 10-Q 14 Jun 2023 2023 Q2
Q1 2023 22,966,615 +6,129 +0.03% 10 Mar 2023 10-Q 17 Mar 2023 2023 Q1
Q4 2022 22,950,321 -19,165 -0.08% 25 Jan 2023 10-K/A 28 Feb 2023 2022 FY
Q3 2022 22,944,286 -84,929 -0.37% 09 Sep 2022 10-Q 14 Sep 2022 2022 Q3
Q2 2022 22,954,086 -75,129 -0.33% 10 Jun 2022 10-Q 14 Jun 2022 2022 Q2
Q1 2022 22,960,486 -68,729 -0.3% 11 Mar 2022 10-Q 17 Mar 2022 2022 Q1
Q4 2021 22,969,486 -59,729 -0.26% 27 Jan 2022 10-K 11 Feb 2022 2021 FY
Q3 2021 23,029,215 +27,588 +0.12% 10 Sep 2021 10-Q 14 Sep 2021 2021 Q3
Q2 2021 23,029,215 +27,588 +0.12% 11 Jun 2021 10-Q 14 Jun 2021 2021 Q2
Q1 2021 23,029,215 +27,588 +0.12% 12 Mar 2021 10-Q 17 Mar 2021 2021 Q1
Q4 2020 23,029,215 +33,334 +0.14% 27 Jan 2021 10-K 01 Feb 2021 2020 FY
Q3 2020 23,001,627 +5,746 +0.02% 10 Sep 2020 10-Q 14 Sep 2020 2020 Q3
Q2 2020 23,001,627 +5,346 +0.02% 12 Jun 2020 10-Q 15 Jun 2020 2020 Q2
Q1 2020 23,001,627 -1,654 -0.01% 14 Mar 2020 10-Q 16 Mar 2020 2020 Q1
Q4 2019 22,995,881 -2,002 -0.01% 24 Jan 2020 10-K 29 Jan 2020 2019 FY
Q3 2019 22,995,881 -66,650 -0.29% 12 Sep 2019 10-Q 16 Sep 2019 2019 Q3
Q2 2019 22,996,281 -66,250 -0.29% 12 Jun 2019 10-Q 14 Jun 2019 2019 Q2
Q1 2019 23,003,281 -59,250 -0.26% 14 Mar 2019 10-Q 18 Mar 2019 2019 Q1
Q4 2018 22,997,883 -64,648 -0.28% 25 Jan 2019 10-K 29 Jan 2019 2018 FY
Q3 2018 23,062,531 -39,400 -0.17% 07 Sep 2018 10-Q 14 Sep 2018 2018 Q3
Q2 2018 23,062,531 -39,400 -0.17% 09 Jun 2018 10-Q 14 Jun 2018 2018 Q2
Q1 2018 23,062,531 -50,800 -0.22% 15 Mar 2018 10-Q 19 Mar 2018 2018 Q1
Q4 2017 23,062,531 -51,000 -0.22% 25 Jan 2018 10-K 29 Jan 2018 2017 FY
Q3 2017 23,101,931 +92,615 +0.4% 07 Sep 2017 10-Q 14 Sep 2017 2017 Q3
Q2 2017 23,101,931 +86,011 +0.37% 09 Jun 2017 10-Q 14 Jun 2017 2017 Q2
Q1 2017 23,113,331 +95,761 +0.42% 13 Mar 2017 10-Q 17 Mar 2017 2017 Q1
Q4 2016 23,113,531 +85,561 +0.37% 26 Jan 2017 10-K 31 Jan 2017 2016 FY
Q3 2016 23,009,316 -52,934 -0.23% 09 Sep 2016 10-Q 14 Sep 2016 2016 Q3
Q2 2016 23,015,920 -55,680 -0.24% 10 Jun 2016 10-Q 14 Jun 2016 2016 Q2
Q1 2016 23,017,570 -71,130 -0.31% 11 Mar 2016 10-Q 16 Mar 2016 2016 Q1
Q4 2015 23,027,970 +39,458 +0.17% 28 Jan 2016 10-K 29 Jan 2016 2015 FY
Q3 2015 23,062,250 +14,788 +0.06% 10 Sep 2015 10-Q 14 Sep 2015 2015 Q3
Q2 2015 23,071,600 +22,138 +0.1% 12 Jun 2015 10-Q 15 Jun 2015 2015 Q2
Q1 2015 23,088,700 +39,238 +0.17% 13 Mar 2015 10-Q 17 Mar 2015 2015 Q1
Q4 2014 22,988,512 -54,582 -0.24% 28 Jan 2015 10-K 29 Jan 2015 2014 FY
Q3 2014 23,047,462 +345,276 +1.5% 11 Sep 2014 10-Q 15 Sep 2014 2014 Q3
Q2 2014 23,049,462 +384,776 +1.7% 13 Jun 2014 10-Q 16 Jun 2014 2014 Q2
Q1 2014 23,049,462 +384,776 +1.7% 14 Mar 2014 10-Q 17 Mar 2014 2014 Q1
Q4 2013 23,043,094 +2,284,399 +11% 28 Jan 2014 10-K 29 Jan 2014 2013 FY
Q3 2013 22,702,186 +1,943,491 +9.4% 13 Sep 2013 10-Q 16 Sep 2013 2013 Q3
Q2 2013 22,664,686 +1,905,991 +9.2% 13 Jun 2013 10-Q 14 Jun 2013 2013 Q2
Q1 2013 22,664,686 +1,905,991 +9.2% 14 Mar 2013 10-Q 18 Mar 2013 2013 Q1
Q4 2012 20,758,695 +14,386,386 +226% 28 Jan 2013 10-K 29 Jan 2013 2012 FY
Q3 2012 20,758,695 0 0% 10 Sep 2012 10-Q 14 Sep 2012 2012 Q3
Q2 2012 20,758,695 13 Jun 2012 10-Q 14 Jun 2012 2012 Q2
Q1 2012 20,758,695 14 Mar 2012 10-Q 16 Mar 2012 2012 Q1
Q4 2011 6,372,309 30 Jan 2012 10-K 30 Jan 2012 2011 FY
Q3 2011 20,758,695 09 Sep 2011 10-Q 14 Sep 2011 2011 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.